Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duvelisib for Severe COVID-19 Pneumonia
NCT04487886Phase 2Completed
- Sponsor
- Emory University
- Start
- Nov 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duvelisib in COVID-19 pneumonia, sponsored by Emory University. Started Nov 2020; status: completed.
02
Drugs
duvelisib
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04487886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04487886.